Men | Women | p Value* | |||||
---|---|---|---|---|---|---|---|
N=466 (75.2%) | N=154 (24.8%) | ||||||
N | %/mean | SD | N | %/mean | SD | ||
(A) Patient's characteristics | |||||||
Age (years) | 466 | 60.4 | 14.5 | 154 | 64.3 | 15.9 | 0.005 |
Hypertension | 171 | 36.7 | 70 | 45.5 | 0.05 | ||
Diabetes mellitus | 83 | 17.8 | 38 | 24.7 | 0.06 | ||
Cancer | 62 | 13.3 | 24 | 15.6 | 0.48 | ||
Haemodialysis | 9 | 1.9 | 8 | 5.2 | 0.04 | ||
Immunosuppression | 29 | 6.2 | 10 | 6.5 | 0.90 | ||
Current smoker | 119 | 26.3 | 21 | 14.0 | 0.002 | ||
Intravenous drug users | 15 | 3.2 | 3 | 1.9 | 0.58 | ||
History of valve disease | 0.98 | ||||||
No known valve disease | 240 | 51.5 | 80 | 51.9 | |||
Native valve disease | 131 | 28.1 | 42 | 27.3 | |||
Prosthetic valve | 95 | 20.4 | 32 | 20.8 | |||
(B) Characteristics of IE: | |||||||
Microorganisms: | |||||||
Oral streptococci | 95 | 20.4 | 31 | 20.1 | 0.95 | ||
Group D streptococci | 107 | 23.0 | 20 | 13.0 | 0.008 | ||
Pyogenic streptococci | 20 | 4.3 | 16 | 10.4 | 0.005 | ||
Enterococci | 48 | 10.3 | 12 | 7.8 | 0.36 | ||
Other Streptococcaceae | 10 | 2.1 | 4 | 2.6 | 0.76 | ||
Staphylococcus aureus | 95 | 20.4 | 35 | 22.7 | 0.54 | ||
Coagulase negative staphylococci | 26 | 5.6 | 12 | 7.8 | 0.32 | ||
Other micro-organism | 34 | 7.3 | 9 | 5.8 | 0.54 | ||
Location of IE: | 0.02 | ||||||
Aortic | 204 | 43.8 | 54 | 35.1 | |||
Mitral | 165 | 35.4 | 77 | 50.0 | |||
Aortic and mitral | 82 | 17.6 | 19 | 12.3 | |||
Echocardiography findings: | |||||||
Size of vegetation | 0.55 | ||||||
No vegetation | 38 | 8.2 | 15 | 9.7 | |||
<10 mm | 108 | 23.2 | 43 | 27.9 | |||
≥10 mm | 216 | 46.4 | 65 | 42.2 | |||
Unknown size | 104 | 22.3 | 31 | 20.1 | |||
Perforation | 77 | 16.5 | 18 | 11.7 | 0.15 | ||
Intracardiac abscess | 106 | 22.7 | 23 | 14.9 | 0.04 | ||
Severe regurgitation | 216 | 48.3 | 53 | 35.1 | 0.005 | ||
(C) Clinical and biological events: | |||||||
Fever | 409 | 88.3 | 139 | 90.3 | 0.51 | ||
Heart failure | 145 | 31.7 | 40 | 27.2 | 0.31 | ||
Septic shock | 41 | 9.0 | 6 | 4.0 | 0.05 | ||
Vascular event | 217 | 46.6 | 68 | 44.2 | 0.60 | ||
Cerebral embolism | 105 | 22.5 | 32 | 20.8 | 0.65 | ||
Other vascular event | 173 | 37.1 | 51 | 33.1 | 0.37 | ||
Creatinine >180 µmol/L | 138 | 30.4 | 40 | 26.5 | 0.36 | ||
CRP >120 mg/L | 188 | 42.9 | 77 | 53.5 | 0.03 | ||
EVS | 244 | 52.4 | 57 | 37.0 | 0.001 | ||
Time from admission to EVS | 28.0 | 37.5 | 24.0 | 26.8 | 0.26 | ||
Inhospital mortality | 93 | 20.0 | 31 | 20.1 | 0.96 | ||
1-year mortality | 116 | 24.9 | 41 | 26.6 | 0.67 |
*χ2 test or Fisher's exact test for qualitative variables, Student's test or Wilcoxon test for quantitative variables.
CRP, C reactive protein; EVS, early valve surgery.